 Figure 1 Day 28 Improvement in Motor Control vs Day 0 Figure 2 Percentage of Patients Experiencing 30 Improvement at Day 28 vs. Day 0 NE3107-treated patients experienced greater motor control in Parkinsons trial Patients treated with the combination of NE3107 and levodopa saw improvements in their UPDRS Part 3 motor score that is 3 ... The post BioVie Announces Positive Results for NE3107 in Parkinsons and Alzheimers Phase 2 Trials appeared first on ForexTV... 